Case Study: Celerion achieves 28% higher screening pass rates with Grove AI

Celerion Increases Screening Pass Rate by 28% with Grove AI

Celerion, a top Phase I clinical research organization (CRO), faced challenges with manual participant recruitment workflows. These processes led to high screening failure costs, significant recruitment delays, and labor-intensive operations that hindered scalability. To address this, Celerion partnered with Grove AI to implement its Grace AI agent and Grove AI PRM™ platform.

The solution from Grove AI used AI-driven participant matching to prescreen 39,000 individuals and autonomously engage the most eligible candidates. This resulted in a 28% increase in screening pass rates and over $20,000 in cost savings for a single trial. Grove AI's agent also scheduled 40 participants in just two days, dramatically improving recruitment efficiency and operational scalability for Celerion.

Celerion

Philip Bach

Executive Vice President, Global Clinical Research